Literature DB >> 2496199

Dopamine release in rat striatum: physiological coupling to tyrosine supply.

M J During1, I N Acworth, R J Wurtman.   

Abstract

Intracerebral microdialysis was used to monitor dopamine release in rat striatal extracellular fluid following the intraperitoneal administration of dopamine's precursor amino acid, L-tyrosine. Dopamine concentrations in dialysates increased transiently after tyrosine (50-100 mg/kg) administration. Pretreatment with haloperidol or the partial lesioning of nigrostriatal neurons enhanced the effect of tyrosine on dopamine release, and haloperidol also prolonged this effect. These data suggest that nigrostriatal dopaminergic neurons are responsive to changes in precursor availability under basal conditions, but that receptor-mediated feedback mechanisms limit the magnitude and duration of this effect.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496199     DOI: 10.1111/j.1471-4159.1989.tb09192.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.

Authors:  Joseph M Breier; Michael G Bankson; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

Review 2.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Authors:  Richard J Wurtman; Mehmet Cansev; Toshimasa Sakamoto; Ismael Ulus
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

3.  Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine.

Authors:  Brena P Teodorak; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Letícia J Teixeira; Joyce Rebelo; Samira D T De Prá; Neila Zeni; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-12-06       Impact factor: 3.584

Review 4.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

5.  Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.

Authors:  George E Jaskiw; Bobbi Kirkbride; Erica Newbould; Damon Young; Valerie Durkalski; Rodolfo Bongiovanni
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

6.  Differential modulation of dopaminergic systems in the rat brain by dietary protein.

Authors:  S M Farooqui; J W Brock; E S Onaivi; A Hamdi; C Prasad
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

7.  In rats chronically treated with clozapine, tyrosine depletion attenuates the clozapine-induced in vivo increase in prefrontal cortex dopamine and norepinephrine levels.

Authors:  George E Jaskiw; Bobbi Kirkbride; Rodolfo Bongiovanni
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530

8.  L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat.

Authors:  Zachary D Brodnik; Manda Double; Rodrigo A España; George E Jaskiw
Journal:  Neuropharmacology       Date:  2017-05-29       Impact factor: 5.250

9.  Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.

Authors:  George E Jaskiw; Rodolfo Bongiovanni
Journal:  Psychopharmacology (Berl)       Date:  2003-10-28       Impact factor: 4.530

10.  The catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress.

Authors:  Harris R Lieberman; Lauren A Thompson; Christina M Caruso; Philip J Niro; Caroline R Mahoney; James P McClung; Gregory R Caron
Journal:  Psychopharmacology (Berl)       Date:  2014-09-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.